Mi Li

3.5k total citations · 2 hit papers
118 papers, 2.1k citations indexed

About

Mi Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mi Li has authored 118 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 22 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mi Li's work include Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (5 papers) and Congenital Heart Disease Studies (5 papers). Mi Li is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (5 papers) and Congenital Heart Disease Studies (5 papers). Mi Li collaborates with scholars based in China, United States and Hong Kong. Mi Li's co-authors include Jing‐Feng Li, Zhiliang Yao, Weiqing Yang, Xijie Yu, Ge Lin, Fan Zhang, Jiang Zheng, Yan Zhou, Hong‐Xi Xu and Na Li and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Mi Li

112 papers receiving 2.1k citations

Hit Papers

A review on the alternatives to antibiotics and the treat... 2024 2026 2025 2024 2024 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mi Li China 25 999 263 237 226 218 118 2.1k
Fei Li China 29 1.0k 1.0× 242 0.9× 360 1.5× 228 1.0× 131 0.6× 112 2.4k
Shu Wang China 30 1.4k 1.4× 268 1.0× 285 1.2× 214 0.9× 142 0.7× 144 3.3k
Qian Ba China 28 945 0.9× 143 0.5× 333 1.4× 253 1.1× 198 0.9× 62 2.1k
Xin Huang China 31 1.2k 1.2× 367 1.4× 472 2.0× 164 0.7× 304 1.4× 194 3.1k
Lijing Zhang China 27 1.1k 1.1× 157 0.6× 233 1.0× 380 1.7× 94 0.4× 119 2.4k
Xing Li China 30 1.6k 1.6× 193 0.7× 199 0.8× 217 1.0× 144 0.7× 102 3.0k
Zhijun Yang Hong Kong 33 1.6k 1.6× 132 0.5× 313 1.3× 356 1.6× 310 1.4× 97 3.4k
Dai Li China 25 982 1.0× 194 0.7× 192 0.8× 284 1.3× 75 0.3× 106 1.9k
Yujing Liu China 30 1.5k 1.5× 176 0.7× 252 1.1× 421 1.9× 103 0.5× 166 3.3k
Georg Damm Germany 29 1.2k 1.2× 528 2.0× 292 1.2× 224 1.0× 301 1.4× 68 2.7k

Countries citing papers authored by Mi Li

Since Specialization
Citations

This map shows the geographic impact of Mi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Li more than expected).

Fields of papers citing papers by Mi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Li. The network helps show where Mi Li may publish in the future.

Co-authorship network of co-authors of Mi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mi Li. A scholar is included among the top collaborators of Mi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi Li. Mi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qianru, Huilin Yang, Rong‐Mei Gao, et al.. (2025). Antiviral prenylated C6–C3 derivatives containing a methylenedioxyl group from the roots of Illicium brevistylum. Phytochemistry. 235. 114462–114462.
2.
Zhang, Wei, et al.. (2024). Knowledge, attitudes, and practices among medical students toward depression management: a cross-sectional study in China. Frontiers in Public Health. 12. 1429943–1429943. 1 indexed citations
3.
Hu, Fen, Yuxi Sun, Yunfeng Zhang, et al.. (2024). Maslinic acid induces autophagy and ferroptosis via transcriptomic and metabolomic reprogramming in prostate cancer cells. Frontiers in Pharmacology. 15. 1453447–1453447. 1 indexed citations
4.
Li, Mi, Amriti R. Lulla, Spyros Tsavachidis, et al.. (2024). Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer. Cancer Research. 84(22). 3864–3880. 4 indexed citations
5.
Wang, Zhengwei, et al.. (2023). The effectiveness of early surgical stabilization for multiple rib fractures: a multicenter randomized controlled trial. Journal of Cardiothoracic Surgery. 18(1). 118–118. 18 indexed citations
6.
Li, Mi, et al.. (2023). [Formononetin enhances the antitumor effect of H22 hepatoma transplanted mice].. PubMed. 39(12). 1063–1068. 1 indexed citations
7.
Nguyen, Tuyen Duong Thanh, Tuyen Bui, Rossana Lazcano, et al.. (2023). Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. Cancer Research. 83(6). 939–955. 3 indexed citations
8.
Liao, Xiaoyu, Xin Li, Xuemei Qiu, et al.. (2022). AMPK phosphorylates NAMPT to regulate NAD + homeostasis under ionizing radiation. Open Biology. 12(10). 220213–220213. 14 indexed citations
9.
Lu, Haofeng, et al.. (2022). Expression of PD-L1 and PD-1 in stage T4 rectal cancer tissues and surrounding metastatic lymph nodes and correlation with prognosis. Cellular and Molecular Biology. 68(8). 74–78. 3 indexed citations
10.
Feng, Xu, Mengfan Tang, Merve Dede, et al.. (2022). Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors. Science Advances. 8(19). eabm6638–eabm6638. 25 indexed citations
12.
Li, Mi, et al.. (2021). A systematic review of pharmacological activities, toxicological mechanisms and pharmacokinetic studies on Aconitum alkaloids. Chinese Journal of Natural Medicines. 19(7). 505–520. 38 indexed citations
13.
14.
Lu, Haofeng, et al.. (2020). Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 87(2). 217–228. 16 indexed citations
16.
Chen, Rui, Daming Dong, Yansong Wang, et al.. (2014). Serum fatty acid profiles and potential biomarkers of ankylosing spondylitis determined by gas chromatography–mass spectrometry and multivariate statistical analysis. Biomedical Chromatography. 29(4). 604–611. 27 indexed citations
17.
Li, Mi. (2014). Interaction between FTO gene polymorphism and life style may contribute to obesity in Kazakh schoolchildren. Yixue yanjiusheng xuebao. 1 indexed citations
18.
Li, Mi. (2013). Diagnostic value of automated breast volume scanner images on benign and malignant breast masses. 1 indexed citations
19.
Li, Mi. (2006). [Zhang Zhongjings lost formulas not included in Shanghan Lun (Treatise on Cold Pathogenic Diseases)].. PubMed. 36(3). 137–41. 2 indexed citations
20.
Tao, Sha, et al.. (2005). Sequence analysis of the internal transcribed spacer of gene coding for rRNA in {\sl Tricholoma matsutake} and {\sl Tricholoma bakamatsutake}. Mycosystema. 24(1). 48–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026